MacroGenics
MGNX
#9452
Rank
ยฃ95.71 M
Marketcap
ยฃ1.50
Share price
-1.01%
Change (1 day)
38.01%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2026 (TTM): -ยฃ78.9 Million

According to MacroGenics's latest financial reports the company's current earnings are ยฃ0.16 Billion. In 2025 the company made an earning of -ยฃ62.48 Million a decrease over its 2024 earnings that were of -ยฃ50.46 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ78.9 Million26.29%
2025 -ยฃ62.48 Million23.83%
2024 -ยฃ50.46 Million628.88%
2023 -ยฃ6.93 Million-92.44%
2022 -ยฃ91.52 Million-40.75%
2021 -ยฃ0.16 Billion55.79%
2020 -ยฃ99.15 Million-14.54%
2019 -ยฃ0.12 Billion-11.46%
2018 -ยฃ0.14 Billion773.65%
2017 -ยฃ15 Million-66.47%
2016 -ยฃ44.73 Million190.61%
2015 -ยฃ15.39 Million-47.43%
2014 -ยฃ29.28 Million14585.78%
2013 -ยฃ0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.32 B-6,766.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ26.56 B-33,363.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.44 B-10,673.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.94 Billion 2,323.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.13 B-6,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.65 B-10,941.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ88.31 Million 10.56%๐Ÿ‡บ๐Ÿ‡ธ USA